Hans H. Storm mainly investigates Cancer, Internal medicine, Oncology, Risk factor and Surgery. His biological study spans a wide range of topics, including Survival rate, Incidence, Pathology and Confidence interval. As a part of the same scientific family, Hans H. Storm mostly works in the field of Incidence, focusing on Epidemiology and, on occasion, Cohort study.
His work in Internal medicine tackles topics such as Gynecology which are related to areas like Hazard ratio and Colorectal cancer. Hans H. Storm combines subjects such as Breast cancer, Epidemiology of cancer, Chemotherapy and Cervix with his study of Oncology. His Surgery study integrates concerns from other disciplines, such as Odds ratio, Absolute risk reduction, Cohort and Cancer registration.
Hans H. Storm mostly deals with Cancer, Internal medicine, Incidence, Oncology and Surgery. His Cancer research includes elements of Epidemiology and Risk factor. His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Gynecology.
He has researched Incidence in several fields, including Mortality rate, Pediatrics and Lymphoma. His study looks at the intersection of Oncology and topics like Cervical cancer with Cervix. His Surgery research incorporates themes from Skin cancer, Cohort study, Cohort and Confidence interval.
His primary areas of investigation include Cancer, Incidence, Internal medicine, Cancer prevention and Cancer registry. His Cancer research incorporates elements of Pediatrics and Public health. His Incidence research is multidisciplinary, incorporating elements of Liver transplantation, Surgery and Skin cancer.
Hans H. Storm frequently studies issues relating to Oncology and Internal medicine. His Cancer registry research focuses on Survival analysis and how it relates to Global health and Health care. His Relative survival research integrates issues from Survival rate and Liver cancer.
His main research concerns Cancer, Incidence, Cancer registry, Internal medicine and Relative survival. The various areas that Hans H. Storm examines in his Cancer study include Cohort study and Pathology. His work in Incidence covers topics such as Skin cancer which are related to areas like Risk factor, Mortality rate, Gerontology and Solid organ transplantation.
His Internal medicine study combines topics from a wide range of disciplines, such as Surgery and Oncology. His study in Relative survival is interdisciplinary in nature, drawing from both Cancer prevention, Cause of death and Public health. While the research belongs to areas of Breast cancer, Hans H. Storm spends his time largely on the problem of Survival analysis, intersecting his research to questions surrounding Stomach cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Claudia Allemani;Hannah K Weir;Helena Carreira;Rhea Harewood.
The Lancet (2015)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Claudia Allemani;Tomohiro Matsuda;Veronica Di Carlo;Rhea Harewood.
The Lancet (2018)
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Michel P. Coleman;Manuela Quaresma;Franco Berrino;Jean Michel Lutz.
Lancet Oncology (2008)
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Lois B. Travis;Sophie D. Fosså;Sara J. Schonfeld;Mary L. McMaster.
Journal of the National Cancer Institute (2005)
Cancer risk after renal transplantation in the Nordic countries, 1964-1986.
Sven A. Birkeland;Hans H. Storm;Lars U. Lamm;Lotti Barlow.
International Journal of Cancer (1995)
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
Lois B. Travis;Deirdre A. Hill;Graça M. Dores;Mary Gospodarowicz.
JAMA (2003)
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
M.P. Coleman;G. Gatta;A. Verdecchia;J. Estève.
Annals of Oncology (2003)
TESTICULAR CANCER IN NINE NORTHERN EUROPEAN COUNTRIES
Hans‐Olov ‐O Adami;Hans‐Olov ‐O Adami;Reinhold Bergström;Matthias Möhner;Witold Zatoôski.
International Journal of Cancer (1994)
Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years
Graça M. Dores;Catherine Metayer;Rochelle E. Curtis;Charles F. Lynch.
Journal of Clinical Oncology (2002)
Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease
Lois B. Travis;Mary Gospodarowicz;Rochelle E. Curtis;E. Aileen Clarke.
Journal of the National Cancer Institute (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Tampere University
University of Iowa
Karolinska Institute
University of Helsinki
University of Helsinki
The University of Texas MD Anderson Cancer Center
Oslo University Hospital
International Agency For Research On Cancer
Antoni van Leeuwenhoek Hospital
University of London
French Institute for Research in Computer Science and Automation - INRIA
University of Alabama
Toyota Motor Corporation (Switzerland)
Helmholtz Centre for Environmental Research
Stanford University
University of California, Los Angeles
Chinese Academy of Sciences
Max Planck Society
Université Catholique de Louvain
University of Duisburg-Essen
Universitat Politècnica de Catalunya
Brigham and Women's Hospital
University College London
Autonomous University of Barcelona
University of Helsinki
Centers for Disease Control and Prevention